The Cooper Companies, Inc. (BVMF:C1OO34)

Market Cap	70.79B -26.6%
Revenue (ttm)	21.75B +5.7%
Net Income	2.10B -3.4%
EPS	10.51 -3.0%
Shares Out	n/a
PE Ratio	33.67
Forward PE	15.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11
Average Volume	41
Open	37.56
Previous Close	n/a
Day's Range	36.22 - 37.56
52-Week Range	33.76 - 48.05
Beta	1.03
RSI	35.37
Earnings Date	Jun 4, 2026

About The Cooper Companies

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1958
• Employees: 15,000
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: C1OO34

Financial Performance

In fiscal year 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.

Financial numbers in USD